Market News

Impala Asset Management Increased Its Holding in Builders Firstsource (BLDR) by $4.89 Million; Abbott Labs (ABT) Shareholder Nichols & Pratt Advisers Llp Has Cut Position by $442,035

Builders FirstSource, Inc. (NASDAQ:BLDR) Logo

Nichols & Pratt Advisers Llp decreased its stake in Abbott Labs (ABT) by 10.79% based on its latest 2017Q4 regulatory filing with the SEC. Nichols & Pratt Advisers Llp sold 7,755 shares as the company’s stock rose 5.88% while stock markets declined. The institutional investor held 64,136 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $3.66M, down from 71,891 at the end of the previous reported quarter. Nichols & Pratt Advisers Llp who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $108.19 billion market cap company. The stock increased 1.06% or $0.65 during the last trading session, reaching $61.71. About 6.36 million shares traded or 0.69% up from the average. Abbott Laboratories (NYSE:ABT) has risen 34.85% since May 20, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Robert Bishop increased its stake in Builders Firstsource Inc (BLDR) by 30.71% based on its latest 2017Q4 regulatory filing with the SEC. Impala Asset Management Llc bought 232,628 shares as the company’s stock declined 7.53% with the market. The hedge fund run by Robert Bishop held 990,223 shares of the consumer services company at the end of 2017Q4, valued at $21.58 million, up from 757,595 at the end of the previous reported quarter. Impala Asset Management Llc who had been investing in Builders Firstsource Inc for a number of months, seems to be bullish on the $2.27B market cap company. The stock increased 4.10% or $0.78 during the last trading session, reaching $19.79. About 967,787 shares traded. Builders FirstSource, Inc. (NASDAQ:BLDR) has risen 35.87% since May 20, 2017 and is uptrending. It has outperformed by 24.32% the S&P500.

Nichols & Pratt Advisers Llp, which manages about $1.58B and $1.15 billion US Long portfolio, upped its stake in Kinder Morgan Inc Del (NYSE:KMI) by 136,710 shares to 744,259 shares, valued at $13.49M in 2017Q4, according to the filing. It also increased its holding in Amazon Com Inc (NASDAQ:AMZN) by 824 shares in the quarter, for a total of 3,340 shares, and has risen its stake in Vanguard Intl Equity Index F (VWO).

Investors sentiment increased to 0.91 in 2017 Q4. Its up 0.04, from 0.87 in 2017Q3. It increased, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. The Georgia-based Vident Advisory Ltd Liability Co has invested 0.02% in Abbott Laboratories (NYSE:ABT). D L Carlson Grp has invested 0.51% in Abbott Laboratories (NYSE:ABT). Profund Advsr Ltd has 0.14% invested in Abbott Laboratories (NYSE:ABT) for 63,051 shares. First Merchants reported 0.64% in Abbott Laboratories (NYSE:ABT). Orrstown Serv invested 1.21% of its portfolio in Abbott Laboratories (NYSE:ABT). Keating Investment Counselors reported 0.14% of its portfolio in Abbott Laboratories (NYSE:ABT). Brookmont Cap Mgmt has 110,995 shares. Eagle Asset Inc stated it has 402,803 shares or 0.13% of all its holdings. Duncker Streett Company owns 59,152 shares or 0.87% of their US portfolio. Tci Wealth Advisors holds 0.52% of its portfolio in Abbott Laboratories (NYSE:ABT) for 20,814 shares. Bluemountain Management stated it has 0.03% in Abbott Laboratories (NYSE:ABT). 122,929 were accumulated by First Manhattan. Whitnell & owns 50,514 shares for 1.21% of their portfolio. Cypress Asset Management Tx stated it has 45,623 shares or 0.56% of all its holdings. Moreover, Pictet And Cie (Europe) has 0.46% invested in Abbott Laboratories (NYSE:ABT).

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. The company was maintained on Wednesday, January 24 by RBC Capital Markets. On Thursday, January 25 the stock rating was maintained by JP Morgan with “Overweight”. The firm has “Overweight” rating by Morgan Stanley given on Tuesday, January 2. The rating was downgraded by Goldman Sachs to “Neutral” on Friday, November 13. The stock of Abbott Laboratories (NYSE:ABT) earned “Overweight” rating by JP Morgan on Tuesday, January 2. Jefferies maintained the stock with “Buy” rating in Tuesday, October 10 report. The rating was maintained by Morgan Stanley with “Equal-Weight” on Tuesday, July 11. The rating was maintained by BMO Capital Markets on Thursday, August 31 with “Hold”. The stock of Abbott Laboratories (NYSE:ABT) earned “Buy” rating by William Blair on Thursday, January 25. The firm has “Buy” rating given on Thursday, July 23 by Stifel Nicolaus.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 19. They expect $0.71 EPS, up 14.52% or $0.09 from last year’s $0.62 per share. ABT’s profit will be $1.24B for 21.73 P/E if the $0.71 EPS becomes a reality. After $0.59 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 20.34% EPS growth.

Since December 14, 2017, it had 1 insider purchase, and 20 sales for $23.69 million activity. Ford Robert B sold 42,665 shares worth $2.69M. Shares for $96,728 were sold by BIRD ROGER on Wednesday, February 28. 3,000 shares were sold by Watkin Jared, worth $183,579. Salvadori Daniel Gesua Sive also sold $1.56 million worth of Abbott Laboratories (NYSE:ABT) shares. Another trade for 27,733 shares valued at $1.73 million was sold by Blaser Brian J. $126,559 worth of stock was sold by Bracken Sharon J on Monday, March 5.

Investors sentiment decreased to 1 in 2017 Q4. Its down 1.02, from 2.02 in 2017Q3. It turned negative, as 30 investors sold BLDR shares while 79 reduced holdings. 37 funds opened positions while 72 raised stakes. 101.67 million shares or 0.09% less from 101.77 million shares in 2017Q3 were reported. The Ohio-based James Incorporated has invested 0.25% in Builders FirstSource, Inc. (NASDAQ:BLDR). Wall Street Access Asset Management Lc invested in 18,050 shares or 0.62% of the stock. Suntrust Banks owns 23,076 shares for 0% of their portfolio. New York-based Citigroup has invested 0% in Builders FirstSource, Inc. (NASDAQ:BLDR). Swiss State Bank owns 191,900 shares or 0% of their US portfolio. Royal Bank Of Canada reported 4,564 shares stake. Pnc Financial Inc has 68,363 shares. Dreman Value Mgmt L L C holds 0.04% or 2,973 shares. Hap Trading Ltd Limited Liability Company has invested 0.06% in Builders FirstSource, Inc. (NASDAQ:BLDR). Blackrock Inc holds 0.01% of its portfolio in Builders FirstSource, Inc. (NASDAQ:BLDR) for 8.81M shares. Teachers Insur & Annuity Association Of America has 39,780 shares. Thompson Siegel & Walmsley Lc reported 0.01% in Builders FirstSource, Inc. (NASDAQ:BLDR). State Common Retirement Fund stated it has 0% in Builders FirstSource, Inc. (NASDAQ:BLDR). 117,752 were accumulated by Stifel Finance. Janney Montgomery Scott invested 0.01% in Builders FirstSource, Inc. (NASDAQ:BLDR).

Impala Asset Management Llc, which manages about $2.53 billion and $2.82B US Long portfolio, decreased its stake in Century Alum Co (NASDAQ:CENX) by 1.50 million shares to 550,000 shares, valued at $10.80 million in 2017Q4, according to the filing. It also reduced its holding in Rio Tinto Plc (NYSE:RIO) by 356,892 shares in the quarter, leaving it with 2.44M shares, and cut its stake in Smith A O (NYSE:AOS).

Among 11 analysts covering Builders Firstsource (NASDAQ:BLDR), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. Builders Firstsource had 27 analyst reports since August 3, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the shares of BLDR in report on Sunday, January 21 with “Buy” rating. Wedbush maintained Builders FirstSource, Inc. (NASDAQ:BLDR) rating on Thursday, September 7. Wedbush has “Buy” rating and $20.0 target. The stock has “Buy” rating by Deutsche Bank on Tuesday, September 8. Stephens maintained it with “Buy” rating and $27.0 target in Tuesday, January 16 report. Citigroup initiated the shares of BLDR in report on Thursday, September 10 with “Neutral” rating. The firm has “Buy” rating given on Monday, March 7 by Deutsche Bank. The stock of Builders FirstSource, Inc. (NASDAQ:BLDR) earned “Buy” rating by Zacks on Monday, August 10. Credit Suisse initiated Builders FirstSource, Inc. (NASDAQ:BLDR) rating on Thursday, October 8. Credit Suisse has “Neutral” rating and $14 target. The rating was initiated by Wedbush with “Outperform” on Wednesday, September 7. The rating was maintained by FBR Capital with “Buy” on Thursday, March 1.

Since March 1, 2018, it had 0 buys, and 5 selling transactions for $8.79 million activity. SHERMAN FLOYD F also sold $2.12 million worth of Builders FirstSource, Inc. (NASDAQ:BLDR) on Tuesday, March 6. CROW M CHAD also sold $1.14 million worth of Builders FirstSource, Inc. (NASDAQ:BLDR) shares. On Thursday, March 8 Jackson Peter M. sold $256,680 worth of Builders FirstSource, Inc. (NASDAQ:BLDR) or 11,972 shares. Another trade for 194,043 shares valued at $4.20M was made by MCALEENAN DONALD F on Monday, March 12.

Builders FirstSource, Inc. (NASDAQ:BLDR) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *